Human Papillomavirus

NCI Study Finds Testing Effective when Used with ThinPrep Pap Test

Published in Women's Health Weekly, April 15th, 2000

Cytyc Corp., Boxborough, Massachusetts, announced that preliminary results from the on-going U.S. National Cancer Institutes (NCI) ASCUS/LSIL Triage Study (ALTS) suggest that human papillomavirus (HPV) testing may be an effective triage strategy when used in combination with the ThinPrep Pap Test.

The results were presented at the Biennial Meeting of the American Society for Colposcopy and Cervical Pathology in Orlando, Florida, during March 2000.

The five-year study, which uses the ThinPrep Pap Test, is sponsored by the NCI. The study is designed to determine an effective strategy to manage patients with borderline or uncertain Pap results. The...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2000-04-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry